XBI

OIB Trade Alert: XBI

I don’t love the way SPDR S&P Biotech ETF (XBI) is trading. I am recommending we exit our put now with a small loss rather than risk having to roll the position out a week. Current Stock Price: $85.10 Cash in Hand: $0.75 Action: Buy to close the XBI Feb Monthly (2/17) 85 Put Current…

View details

OIB Trade Alert: XBI

I am recommending we sell a put on SPDR S&P Biotech ETF (XBI) to take advantage of the risk-on trade. The sector has outperformed the broader market so far this year, though not by a crazy amount. Given that the biotech sector is more volatile than most, we can collect an attractive premium for selling…

View details

Income Masters Trade Alert: XBI

I am recommending we close our SPDR S&P Biotech ETF (XBI) put early rather than hold through expiration and risk the position turning against us. Our active recovery strategy has allowed us to walk away from a position that was deep underwater – with a net debit as high as $14.77 at one point –…

View details

Income Masters Trade Alert: MRNA, XBI

Moderna (MRNA) has fallen more than 18% in the past two weeks since topping out above $212. This followed a sharp run-up in mid-December on news its personalized vaccine candidate reduces the risk of melanoma recurrence or death by 44% when given to patients in combination with Merck’s (MRK) Keytruda. Some of the selling can…

View details

Income Masters Trade Alert: MRNA, XBI

Moderna (MRNA) is holding onto the big gains it made after it was announced that its personalized vaccine candidate reduces the risk of melanoma recurrence or death by 44% when given to patients in combination with Merck’s (MRK) Keytruda. I am recommending we roll our put out two weeks to generate more income while lowering…

View details